Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
In plain English: that list determines whether licensed compounding pharmacies can legally prepare a substance for individual patients under a prescription
However, if the pain persists or worsens beyond a week, it may indicate a more serious issue
Baseline bloodwork CBC, CRP, ferritin, IL-6, cortisol AM, metabolic panel, thyroid function Cardiovascular assessment heart rate variability, orthostatic vitals if POTS is suspected Gut health markers stool testing, zonulin, calprotectin if GI symptoms are prominent Mitochondrial function proxies lactate, organic acids panel if PEM is a primary complaint From there, a typical protocol might be structured as: Phase 1 (Weeks 16): Immune and gut foundation Thymosin Alpha-1: 1.6 mg subcutaneous, twice weekly BPC-157: 250500 mcg daily, route determined by predominant symptom (oral for gut, injectable for systemic) Phase 2 (Weeks 412): Tissue repair and cardiovascular recovery TB-500: 2.02.5 mg subcutaneous, twice weekly Continue BPC-157 as indicated Phase 3 (Weeks 816): Maintenance and metabolic support Taper or pulse doses based on clinical response Add mitochondrial support if fatigue persists (see: Mitochondrial Peptides and Insulin Resistance) These are illustrative dosing ranges based on clinical research and published protocols
BPC-157 promotes angiogenesis, the formation of new blood vessels, through activation of the VEGF pathway
Explore AOD-9604 from Peptide Works, a growth hormone fragment researched for its role in fat metabolism and weight reduction studies
US$ 20.11
US$ 21.63
US$ 22.57
US$ 28.68
US$ 22.94
US$ 28.00
US$ 27.10
US$ 23.53
